VRNA

VRNA

USD

Verona Pharma plc American Depositary Share

$106.910+0.060 (0.056%)

Precio en Tiempo Real

Healthcare
Biotecnología
Reino Unido

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$106.850

Máximo

$106.910

Mínimo

$106.910

Volumen

1.87M

Fundamentos de la Empresa

Capitalización de Mercado

9.1B

Industria

Biotecnología

País

United Kingdom

Estadísticas de Negociación

Volumen Promedio

1.69M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $31.6Actual $106.910Máximo $106.93

Noticias Relacionadas

Analyst Upgrades

Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target

Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR and Maintains $100 price target

Ver más
Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target
BusinessWire

Merck Completes Acquisition of Verona Pharma

Acquisition strengthens Merck's cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:MRK),

Ver más
Merck Completes Acquisition of Verona Pharma
GlobeNewswire

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on

Ver más
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
GlobeNewswire

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive

Ver más
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.